Literature DB >> 17332089

Coccidioidomycosis in California state correctional institutions.

Demosthenes Pappagianis1.   

Abstract

Coccidioidomycosis (CM) has been recognized in inmates of California State prisons since 1919, where it has been diagnosed in inmates of various correctional facilities inside and outside the known endemic areas. In recent years construction of new prisons within endemic areas has led to an increase in the number of cases of CM. In 2005 and 2006, the Pleasant Valley State Prison (PVSP) near Coalinga and Avenal State Prison (ASP) near Avenal on the western side of the San Joaquin Valley have been particularly affected. In 2005, our serologic testing yielded 150 new cases from PVSP and 30 from ASP. The incidence rate in 2005 for PVSP (population approximately 5,000) was at least 3,000 per 100,000, and this will be exceeded in 2006. Some cases diagnosed in early 2006 likely were infections that were acquired in 2005. Some cases are medically managed on site, but very ill inmates have had care in nonprison facilities. Precise numbers of patients who were hospitalized were not made available to the author. Estimates of the cost per patient have varied from $8,000 in the 1990s to $30,000 more recently. Thus, this disease has important medical, demographic, and financial implications for the state.

Entities:  

Mesh:

Year:  2007        PMID: 17332089     DOI: 10.1196/annals.1406.011

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  13 in total

1.  Call for a California coccidioidomycosis consortium to face the top ten challenges posed by a recalcitrant regional disease.

Authors:  George R Thompson; David A Stevens; Karl V Clemons; Josh Fierer; Royce H Johnson; Jane Sykes; George Rutherford; Michael Peterson; John W Taylor; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2014-10-16       Impact factor: 2.574

2.  Awareness and Environmental Exposures Related to Coccidioidomycosis Among Inmates at Two California Prisons, 2013.

Authors:  Kaitlin Benedict; Anne E Purfield; Janet Mohle-Boetani; Charlotte Wheeler; Benjamin J Park
Journal:  J Correct Health Care       Date:  2016-04

3.  Increased Coccidioidomycosis Among Inmates at a California Prison: Initial Investigation in 2005 to 2006.

Authors:  Lauren A Lee; Jean Yuan; Duc Vugia; Charlotte Wheeler; Robert Chapnick; Janet Mohle-Boetani
Journal:  J Correct Health Care       Date:  2017-06-28

4.  What's Behind the Increasing Rates of Coccidioidomycosis in Arizona and California?

Authors:  Neil M Ampel
Journal:  Curr Infect Dis Rep       Date:  2010-05       Impact factor: 3.725

5.  Increasing incidence and severity of coccidioidomycosis at a naval air station.

Authors:  Rachel Lee; Nancy Crum-Cianflone
Journal:  Mil Med       Date:  2008-08       Impact factor: 1.437

Review 6.  The public health impact of coccidioidomycosis in Arizona and California.

Authors:  Richard F Hector; George W Rutherford; Clarisse A Tsang; Laura M Erhart; Orion McCotter; Shoana M Anderson; Kenneth Komatsu; Farzaneh Tabnak; Duc J Vugia; Ying Yang; John N Galgiani
Journal:  Int J Environ Res Public Health       Date:  2011-04-15       Impact factor: 3.390

7.  Coccidioidomycosis: epidemiology.

Authors:  Jennifer Brown; Kaitlin Benedict; Benjamin J Park; George R Thompson
Journal:  Clin Epidemiol       Date:  2013-06-25       Impact factor: 4.790

8.  Coccidioidomycosis-associated hospitalizations, California, USA, 2000-2011.

Authors:  Gail Sondermeyer; Lauren Lee; Debra Gilliss; Farzaneh Tabnak; Duc Vugia
Journal:  Emerg Infect Dis       Date:  2013-10       Impact factor: 6.883

Review 9.  Occupational Respiratory Infections.

Authors:  Marie A de Perio; Miwako Kobayashi; Jonathan M Wortham
Journal:  Clin Chest Med       Date:  2020-12       Impact factor: 2.878

10.  Coccidioidomycosis-associated Deaths, United States, 1990-2008.

Authors:  Jennifer Y Huang; Benjamin Bristow; Shira Shafir; Frank Sorvillo
Journal:  Emerg Infect Dis       Date:  2012-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.